NanoVibronix Other Liab vs Total Current Liabilities Analysis

NAOV Stock

USD 0.73 0.01 1.39%

NanoVibronix financial indicator trend analysis is infinitely more than just investigating NanoVibronix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NanoVibronix is a good investment. Please check the relationship between NanoVibronix Other Liab and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.

Other Liab vs Total Current Liabilities

Other Liab vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NanoVibronix Other Liab account and Total Current Liabilities. At this time, the significance of the direction appears to have no relationship.

The correlation between NanoVibronix's Other Liab and Total Current Liabilities is 0.07. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of NanoVibronix, assuming nothing else is changed. The correlation between historical values of NanoVibronix's Other Liab and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of NanoVibronix are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Other Liab i.e., NanoVibronix's Other Liab and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.07

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Other Liab

Total Current Liabilities

Total Current Liabilities is an item on NanoVibronix balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NanoVibronix are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from NanoVibronix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NanoVibronix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.At this time, NanoVibronix's Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 0.39 in 2024, whereas Selling General Administrative is likely to drop slightly above 2.4 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	770K	167K	1.5M	1.6M
Total Revenue	1.7M	752K	2.3M	2.4M

Gross Profit Total Revenue

NanoVibronix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Inventory	Other Liab	Current Deferred Revenue
Total Assets		-0.53	0.82	0.24	0.83	0.42	-0.9	-0.79	0.43	0.95	-0.11	-0.23	0.95	0.52	-0.41	0.66	-0.17	0.55	0.86	0.14	0.22	1.0	-0.2	0.4	0.09	0.01
Short Long Term Debt Total	-0.53		-0.4	0.55	-0.78	-0.01	0.78	0.58	-0.45	-0.5	0.57	0.57	-0.5	-0.4	-0.07	-0.45	0.03	-0.29	-0.62	0.54	0.05	-0.55	0.73	-0.33	-0.16	-0.47
Other Current Liab	0.82	-0.4		0.44	0.68	0.38	-0.66	-0.9	0.36	0.67	-0.03	-0.14	0.67	0.74	-0.6	0.88	-0.24	0.38	0.81	0.3	0.21	0.82	-0.08	0.76	0.06	-0.18
Total Current Liabilities	0.24	0.55	0.44		-0.19	0.18	0.12	-0.22	0.13	0.15	0.76	0.68	0.15	0.15	-0.32	0.22	-0.23	0.16	0.17	0.84	0.08	0.21	0.7	0.2	0.07	-0.29
Total Stockholder Equity	0.83	-0.78	0.68	-0.19		0.26	-0.9	-0.81	0.41	0.79	-0.4	-0.47	0.79	0.67	-0.22	0.74	-0.38	0.29	0.82	-0.39	0.2	0.84	-0.52	0.52	-0.21	0.02
Property Plant And Equipment Net	0.42	-0.01	0.38	0.18	0.26		-0.24	-0.3	-0.36	0.33	-0.09	-0.28	0.33	-0.05	-0.59	0.32	-0.02	0.05	0.39	0.16	0.92	0.43	-0.07	0.19	-0.11	-0.49
Net Debt	-0.9	0.78	-0.66	0.12	-0.9	-0.24		0.7	-0.48	-0.93	0.31	0.39	-0.93	-0.47	0.21	-0.55	0.05	-0.58	-0.76	0.14	-0.05	-0.91	0.45	-0.27	-0.19	-0.28
Retained Earnings	-0.79	0.58	-0.9	-0.22	-0.81	-0.3	0.7		-0.48	-0.61	0.13	0.21	-0.61	-0.83	0.34	-0.94	0.49	-0.25	-0.94	0.05	-0.24	-0.78	0.21	-0.79	0.16	0.09
Accounts Payable	0.43	-0.45	0.36	0.13	0.41	-0.36	-0.48	-0.48		0.4	0.25	0.29	0.4	0.35	0.45	0.25	-0.28	0.37	0.5	-0.04	-0.46	0.41	0.07	0.16	0.1	0.61
Cash	0.95	-0.5	0.67	0.15	0.79	0.33	-0.93	-0.61	0.4		-0.1	-0.21	1.0	0.39	-0.32	0.47	-0.03	0.64	0.69	0.12	0.11	0.95	-0.21	0.15	0.19	0.12
Non Current Assets Total	-0.11	0.57	-0.03	0.76	-0.4	-0.09	0.31	0.13	0.25	-0.1		0.98	-0.1	-0.21	0.2	-0.19	-0.27	-0.08	-0.15	0.57	-0.07	-0.15	0.67	-0.21	0.03	0.05
Non Currrent Assets Other	-0.23	0.57	-0.14	0.68	-0.47	-0.28	0.39	0.21	0.29	-0.21	0.98		-0.21	-0.21	0.33	-0.27	-0.27	-0.13	-0.24	0.5	-0.24	-0.27	0.66	-0.24	0.03	0.14
Cash And Short Term Investments	0.95	-0.5	0.67	0.15	0.79	0.33	-0.93	-0.61	0.4	1.0	-0.1	-0.21		0.39	-0.32	0.47	-0.03	0.64	0.69	0.12	0.11	0.95	-0.21	0.15	0.19	0.12
Net Receivables	0.52	-0.4	0.74	0.15	0.67	-0.05	-0.47	-0.83	0.35	0.39	-0.21	-0.21	0.39		-0.36	0.9	-0.53	0.04	0.66	-0.13	-0.02	0.52	-0.16	0.81	-0.33	-0.28
Common Stock Total Equity	-0.41	-0.07	-0.6	-0.32	-0.22	-0.59	0.21	0.34	0.45	-0.32	0.2	0.33	-0.32	-0.36		-0.53	-0.18	-0.06	-0.26	-0.42	-0.47	-0.42	0.07	-0.48	-0.09	0.68
Common Stock Shares Outstanding	0.66	-0.45	0.88	0.22	0.74	0.32	-0.55	-0.94	0.25	0.47	-0.19	-0.27	0.47	0.9	-0.53		-0.5	0.02	0.81	-0.05	0.32	0.66	-0.19	0.91	-0.28	-0.36
Non Current Liabilities Total	-0.17	0.03	-0.24	-0.23	-0.38	-0.02	0.05	0.49	-0.28	-0.03	-0.27	-0.27	-0.03	-0.53	-0.18	-0.5		0.38	-0.43	0.34	-0.24	-0.16	-0.04	-0.47	0.8	0.29
Other Current Assets	0.55	-0.29	0.38	0.16	0.29	0.05	-0.58	-0.25	0.37	0.64	-0.08	-0.13	0.64	0.04	-0.06	0.02	0.38		0.31	0.37	-0.31	0.55	-0.1	-0.16	0.56	0.43
Other Stockholder Equity	0.86	-0.62	0.81	0.17	0.82	0.39	-0.76	-0.94	0.5	0.69	-0.15	-0.24	0.69	0.66	-0.26	0.81	-0.43	0.31		-0.08	0.31	0.86	-0.25	0.61	-0.12	0.0
Total Liab	0.14	0.54	0.3	0.84	-0.39	0.16	0.14	0.05	-0.04	0.12	0.57	0.5	0.12	-0.13	-0.42	-0.05	0.34	0.37	-0.08		-0.06	0.11	0.64	-0.05	0.52	-0.12
Property Plant And Equipment Gross	0.22	0.05	0.21	0.08	0.2	0.92	-0.05	-0.24	-0.46	0.11	-0.07	-0.24	0.11	-0.02	-0.47	0.32	-0.24	-0.31	0.31	-0.06		0.23	-0.05	0.23	-0.37	-0.61
Total Current Assets	1.0	-0.55	0.82	0.21	0.84	0.43	-0.91	-0.78	0.41	0.95	-0.15	-0.27	0.95	0.52	-0.42	0.66	-0.16	0.55	0.86	0.11	0.23		-0.23	0.4	0.09	0.01
Common Stock	-0.2	0.73	-0.08	0.7	-0.52	-0.07	0.45	0.21	0.07	-0.21	0.67	0.66	-0.21	-0.16	0.07	-0.19	-0.04	-0.1	-0.25	0.64	-0.05	-0.23		-0.16	0.04	-0.15
Inventory	0.4	-0.33	0.76	0.2	0.52	0.19	-0.27	-0.79	0.16	0.15	-0.21	-0.24	0.15	0.81	-0.48	0.91	-0.47	-0.16	0.61	-0.05	0.23	0.4	-0.16		-0.31	-0.38
Other Liab	0.09	-0.16	0.06	0.07	-0.21	-0.11	-0.19	0.16	0.1	0.19	0.03	0.03	0.19	-0.33	-0.09	-0.28	0.8	0.56	-0.12	0.52	-0.37	0.09	0.04	-0.31		0.58
Current Deferred Revenue	0.01	-0.47	-0.18	-0.29	0.02	-0.49	-0.28	0.09	0.61	0.12	0.05	0.14	0.12	-0.28	0.68	-0.36	0.29	0.43	0.0	-0.12	-0.61	0.01	-0.15	-0.38	0.58

Click cells to compare fundamentals

NanoVibronix Account Relationship Matchups

NanoVibronix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0M	8.2M	8.6M	5.9M	6.7M	3.7M
Other Current Liab	280K	2.3M	1.7M	2.1M	2.3M	2.4M
Total Current Liabilities	409K	2.9M	1.9M	2.3M	2.5M	1.8M
Total Stockholder Equity	1.3M	2.4M	6.3M	3.2M	4.0M	4.2M
Property Plant And Equipment Net	4K	35K	54K	88K	12K	11.4K
Net Debt	(1.3M)	(7.1M)	(7.7M)	(2.6M)	(3.3M)	(3.1M)
Retained Earnings	(38.3M)	(42.7M)	(56.9M)	(62.4M)	(66.1M)	(62.8M)
Accounts Payable	129K	144K	87K	66K	138K	103.5K
Cash	1.3M	7.1M	7.7M	2.7M	3.3M	2.6M
Non Current Assets Total	198K	259K	280K	270K	187K	228.2K
Non Currrent Assets Other	194K	200K	207K	179K	174K	205.0K
Cash And Short Term Investments	1.3M	7.1M	7.7M	2.7M	3.3M	2.6M
Net Receivables	130K	93K	264K	109K	425K	446.3K
Common Stock Shares Outstanding	347.0K	514.9K	1.3M	1.4M	1.8M	1.8M
Liabilities And Stockholders Equity	2.0M	8.2M	8.6M	5.9M	6.7M	3.7M
Non Current Liabilities Total	279K	2.9M	406K	330K	232.0K	220.4K
Other Current Assets	249K	590K	166K	9K	47K	44.7K
Other Stockholder Equity	39.7M	45.0M	63.2M	65.6M	70.1M	36.5M
Total Liab	688K	5.8M	2.3M	2.6M	2.7M	2.2M
Property Plant And Equipment Gross	4K	4.0	54K	88K	12K	11.4K
Total Current Assets	1.8M	8.0M	8.3M	5.6M	6.5M	3.3M
Accumulated Other Comprehensive Income	(54K)	66K	60K	(18K)	(67K)	(70.4K)
Inventory	121K	145K	175K	2.2M	2.7M	2.9M
Other Liab	279K	2.9M	406K	330K	297K	282.2K
Other Assets	194K	255.0	208K	179K	161.1K	216.3K
Net Tangible Assets	1.3M	2.4M	6.3M	3.2M	3.7M	3.9M
Capital Surpluse	32.0M	33.0M	39.7M	45.0M	51.7M	31.5M
Retained Earnings Total Equity	(28.4M)	(32.6M)	(38.3M)	(42.7M)	(38.4M)	(40.3M)
Non Current Liabilities Other	434K	477K	279K	462K	415.8K	796.7K
Net Invested Capital	1.3M	2.4M	6.3M	3.2M	4.0M	3.4M
Net Working Capital	1.4M	5.1M	6.4M	3.3M	4.0M	3.9M
Capital Stock	9K	24K	28K	2K	1.8K	1.7K

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NanoVibronix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NanoVibronix's short interest history, or implied volatility extrapolated from NanoVibronix options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether NanoVibronix is a strong investment it is important to analyze NanoVibronix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NanoVibronix's future performance. For an informed investment choice regarding NanoVibronix Stock, refer to the following important reports:

How To Invest In NanoVibronix

Details

Is NanoVibronix Stock a good investment?

Details

What is NanoVibronix's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NanoVibronix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.

You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for NanoVibronix Stock analysis

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.

	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is NanoVibronix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoVibronix. If investors know NanoVibronix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoVibronix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.12)

Revenue Per Share

1.304

Quarterly Revenue Growth

3.722

Return On Assets

(0.31)

Return On Equity

(1.03)

The market value of NanoVibronix is measured differently than its book value, which is the value of NanoVibronix that is recorded on the company's balance sheet. Investors also form their own opinion of NanoVibronix's value that differs from its market value or its book value, called intrinsic value, which is NanoVibronix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoVibronix's market value can be influenced by many factors that don't directly affect NanoVibronix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between NanoVibronix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoVibronix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoVibronix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NanoVibronix Other Liab vs Total Current Liabilities Analysis

Other Liab vs Total Current Liabilities

Other Liab vs Total Current Liabilities Correlation Analysis

Correlation Coefficient

Other Liab

Total Current Liabilities

NanoVibronix fundamental ratios Correlations

NanoVibronix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

NanoVibronix fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for NanoVibronix Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Non Currrent Assets Other	+ 0.98	Non Current Assets Total
Cash	+ 0.95	Total Assets
Cash And Short Term Investments	+ 0.95	Total Assets
Total Current Assets	+ 0.95	Cash

Other Stockholder Equity	- 0.94	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Cash And Short Term Investments	- 0.93	Net Debt
Cash	- 0.93	Net Debt
Total Current Assets	- 0.91	Net Debt
Net Debt	- 0.9	Total Stockholder Equity